Furthermore, Upregulation of the cell cycle kinase CDC7 has been identified as a key early event in the NE transdifferentiation of lung and prostate cancers that harbor concurrent TP53 and RB1 mutations [290]. Here, TP53 is linked to prostate carcinoma.